SynBiotic SE (SBX.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold SBX.DE in your mock portfolio yet.
SynBiotic SE is currently loss-making, as indicated by its negative EPS and PE ratio. The lack of profitability suggests that the business model has not yet scaled to cover costs, and investors are not being compensated by earnings support at the current share price.
The stock trades at €1.47, significantly below its 200-day moving average of €2.34, indicating a sustained downtrend. A recent 18.2% decline over the last month reinforces negative momentum and weak investor sentiment.
Alternative data show limited digital traction and stagnant or slightly declining audience engagement across key social channels. Very low web traffic, no job openings, and flat-to-declining social followership point to muted growth momentum and a cautious business stance.
Overall, SynBiotic SE’s profile appears bearish, with a loss-making financial position, a stock trading well below its long-term average, and soft alternative data signals. Without clear evidence of improving fundamentals or accelerating user and brand traction, the risk-reward skew remains unfavorable in the near term.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started